Discover the PDT dynamic phototherapy solution made in France, lighting specially designed for the treatment of actinic keratoses.
Product picture
DERMARIS
DERMARIS has been specially designed to treat actinic keratosis (AK) using photodynamic therapy (PDT).
AK is a skin lesion developed by chronic & heavy exposure to the sun that can develop into skin cancer. Protoporphyrin IX (PpIX) is a molecule present in KA cells that multiplies under the effect of the precursor. Aminolevulinic acid methyl ester (MAL) and 5-aminolevulinic acid (5-ALA) are drugs that act as precursors in the treatment of PDT.
PDT is a medical technique aimed at destroying pre-cancerous tissue through the use of photosensitising substances combined with a light source.
This light source offers a constant intensity of 20,000 Lux and a large, homogeneous treatment surface (20 cm).
The DERMARIS irradiance spectrum covers all the absorption peaks of the molecule used to destroy pre-cancerous cells.
ASK FOR A QUOTE 👇
Key features
Benefits
- Ease of use: the lighting is compact and space-saving, making it easy to install patients (less than 2 minutes). Turning off the light head is easy as you just have to tilt it upwards to turn it off
- Unrivalled patient comfort: the treatment is silent
- Long-term use: over 30,000 treatments possible with a treatment time of 2h00
- Durable lighting: DERMARIS has a service life of 60,000 hours and the possibility of using it as examination lighting. Furthermore, the lighting requires no consumables.
Clinical studies
DERMARIS has been used in clinical studies, and here’s what the results show: (studies carried out on 38 people)
Efficacy :
- 58% of patients were free of KA lesions 3 months after treatment
- 32% of patients required a second AWL-PDT treatment
- 10% of patients had one to four KA lesions after 2 treatment
Pain:
- 33 of 38 patients (87%) experienced no pain during treatment
- 5 patients (13%) rated their pain level as 1 on a scale of 10
Post-treatment:
Discomfort in the six days following treatment was rated as :
- Non-existent (34% of patients)
- Mild (63% of patients)
Clinical experience & user studies
Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source – M. Creusot, S. Mordon
“Artificial white light photodynamic therapy for actinic keratosis : a study of 38 patients in private office practice” – C Maire, Anne-Sophie Vignion-Dewalle, H Cartier,
Serge Mordon
“A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging” – Arisia, M. T. Rossia, L. Spiazzib, E. Guasco Pisania, A. Venturuzzoa, C. Rovatia, C. Tomasic, M. Venturinia and P. G. Calzavara-Pintona”
- EURO PDT 2019
First clinical experiences on MAL-PDT with an artificial white light irradiation device (Dermaris®) in patients with multiple AK of the face and scalp: a split face study – Schimtz L.
- EURO PDT 2019
“Simulated daylight (SDL-PDT) treatment of AK with a new LED white light device : clinical results in a prospective observational pilot series in 30 patients – Maire C, Mordon S.
Artificial white light PDT for AK : a study of 38 patients in private office practice – Maire C, Vignion-Dewalle AS, Cartier H.
“Randomised clinical trial of conventional versus indoor daylight photodynamic therapy for the treatment of actinic cheilitis” – M. Arisi et al.
“Traitement des kératoses actiniques grade I et II du visage et du vertex par une heure d’éclairement par photothérapie dynamique en lumière du jour artificielle” – L. Bergmann, M. Quoniou, S. Dalac Rat, G. Jeudy, C. Bedane
Review articles & scientific studies
Thérapie photodynamique par lumière blanche artificielle pour le traitement des kératoses actiniques –S. Mordon, C. Maire
Can daylight-PDT be performed indoor ? – Mordon S, Vignion-Dewalle AS, Thecua E, Vicentini C,
Maire C, Deleporte P, Baert G, Lecomte F, Mortier L.
“Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2020” – Morton CA, Szeimies RM, Braathen LR
Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source – M. Creusot, S. Mordon
Actinic keratosis (AK) is a chronic skin disease with a high prevalence in the Caucasian
population that has increased to even higher numbers in recent years. – M. Creusot, M. Fronville, S. Mordon
Download brochure 👇
Options
Additional protective glasses
Guarantee (& extended guarantee)
FAQ
Customer references
As a private dermatologist, I use photodynamic therapy to treat actinic keratoses.
Day light therapy is an effective treatment, but the use of DERMARIS by SURGIRIS allows an equivalent treatment to be carried out in the office with the same results. This treatment is done without the constraints of the weather. This technique can be performed comfortably in the office, both in summer and winter, without being dependent on rainy or hot weather.
I personally have 2 DERMARIS lamps for a better treatment of 2 “keratosis fields”, in a small dedicated room. Considering the frequency of this pathology, this equipment is quite profitable and useful for the patients.
Related products
For each product family, SURGIRIS offers you its innovative solutions.
WHY CHOOSE SURGIRIS PRODUCTS?
In our production facilities, we create high-performance operating theatre equipment for the most demanding applications.
